127 related articles for article (PubMed ID: 16580826)
1. Novel strategies of aerosolic pharmacotherapy.
Groneberg DA; Paul H; Welte T
Exp Toxicol Pathol; 2006 Jun; 57 Suppl 2():49-53. PubMed ID: 16580826
[TBL] [Abstract][Full Text] [Related]
2. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake.
Groneberg DA; Nickolaus M; Springer J; Döring F; Daniel H; Fischer A
Am J Pathol; 2001 Feb; 158(2):707-14. PubMed ID: 11159208
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport.
Groneberg DA; Fischer A; Chung KF; Daniel H
Am J Respir Cell Mol Biol; 2004 Mar; 30(3):251-60. PubMed ID: 14969997
[TBL] [Abstract][Full Text] [Related]
4. Expression, localisation and functional implications of the transporter protein PEPT2 in the upper respiratory tract.
Quarcoo D; Fischer TC; Heppt W; Lauenstein HD; Pilzner C; Welte T; Groneberg DA
Respiration; 2009; 77(4):440-6. PubMed ID: 19052442
[TBL] [Abstract][Full Text] [Related]
5. Clinical perspectives on pulmonary systemic and macromolecular delivery.
Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
[TBL] [Abstract][Full Text] [Related]
6. [Drug transport in the respiratory epithelium].
Paul HB; Welte T; Groneberg DA
Pneumologie; 2005 Jul; 59(7):461-9. PubMed ID: 16047280
[TBL] [Abstract][Full Text] [Related]
7. Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans.
Hickey AJ; Garcia-Contreras L
Crit Rev Ther Drug Carrier Syst; 2001; 18(4):387-431. PubMed ID: 11605897
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
[TBL] [Abstract][Full Text] [Related]
9. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
Sakagami M
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
[TBL] [Abstract][Full Text] [Related]
10. Other medications for aerosol delivery.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S76-9. PubMed ID: 16798603
[TBL] [Abstract][Full Text] [Related]
11. Adaptive Aerosol Delivery (AAD) technology.
Denyer J; Nikander K; Smith NJ
Expert Opin Drug Deliv; 2004 Nov; 1(1):165-76. PubMed ID: 16296727
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches to enhance pulmonary delivery of proteins and peptides.
Scheuch G; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):615-25. PubMed ID: 18204175
[TBL] [Abstract][Full Text] [Related]
13. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
14. [Advantages and difficulties of aerosol therapy].
Huchon G
Rev Prat; 1992 Sep; 42(13):1657-61. PubMed ID: 1455137
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway.
Bitonti AJ; Dumont JA
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1106-18. PubMed ID: 16997417
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the non-neuronal acetylcholine synthesis and release machinery in acute allergic airway inflammation of rat and mouse.
Lips KS; Lührmann A; Tschernig T; Stoeger T; Alessandrini F; Grau V; Haberberger RV; Koepsell H; Pabst R; Kummer W
Life Sci; 2007 May; 80(24-25):2263-9. PubMed ID: 17328924
[TBL] [Abstract][Full Text] [Related]
17. [Protective effects of ketamine on allergen-induced airway inflammatory injure and high airway reactivity in asthma: experiment with rats].
Zhu MM; Qian YN; Zhu W; Xu YM; Rong HB; Ding ZN; Fu CZ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1308-13. PubMed ID: 17727773
[TBL] [Abstract][Full Text] [Related]
18. Assessment methods of inhaled aerosols: technical aspects and applications.
Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
[TBL] [Abstract][Full Text] [Related]
19. Fundamentals of pulmonary drug delivery.
Groneberg DA; Witt C; Wagner U; Chung KF; Fischer A
Respir Med; 2003 Apr; 97(4):382-7. PubMed ID: 12693798
[TBL] [Abstract][Full Text] [Related]
20. The renal type H+/peptide symporter PEPT2: structure-affinity relationships.
Biegel A; Knütter I; Hartrodt B; Gebauer S; Theis S; Luckner P; Kottra G; Rastetter M; Zebisch K; Thondorf I; Daniel H; Neubert K; Brandsch M
Amino Acids; 2006 Sep; 31(2):137-56. PubMed ID: 16868651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
